Built In Boston on LinkedIn: Ratio Therapeutics Secures $50M …

Skip to main content LinkedIn. Articles ... Join now Sign in Built In Boston’s Post Built In Boston 8,884 followers ... Ratio Therapeutics Secures $50M Series B to Develop Cancer Treatments

CouponFollow Extension

$50
OFF

Built In Boston On LinkedIn: Ratio Therapeutics Secures $50M …

6 days from now

Skip to main content LinkedIn. Articles ... Join now Sign in Built In Boston’s Post Built In Boston 8,884 followers ... Ratio Therapeutics Secures $50M Series B to Develop Cancer Treatments

linkedin.com

$50
OFF

January 17th, 2024: Ratio Therapeutics Announces $50M Series B ...

6 days from now

Jan 17, 2024 · Boston-Based Radiopharmaceutical Company Brings Total Financing to More Than $90Million Since 2021 Launch. BOSTON, January 17, 2024 – Ratio Therapeutics Inc. …

ratiotx.com

$50
OFF

Media - Ratio Therapeutics

6 days from now

Oct 23, 2024 · Ratio Therapeutics secures funds for cancer radiotherapies. Pharmaceutical-Technology.com | January 18th, 2024. ... Boston’s Ratio Therapeutics Raises $50M Series B …

ratiotx.com

$50
OFF

Ratio Therapeutics Announces $50M Series B Financing To …

6 days from now

BOSTON, Jan. 17, 2024 /PRNewswire/ -- Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class …

yahoo.com

$50
OFF

Startup Rise - North America On LinkedIn: [Funding Alert] Boston …

6 days from now

#Boston-based #RatioTherapeutics secures $50M in series B round #funding, bringing the total raised to date to over $90 million. The latest round witnessed…

linkedin.com

$50
OFF

Ratio Therapeutics Raises $50M For Tumor-targeting …

6 days from now

Jan 17, 2024 · The company also announced plans to move into its new, 19,000-square-foot facility in Boston's Seaport District, which it officially opened in May 2023. Hoppin said the …

bizjournals.com

$3
OFF

Built In Boston On LinkedIn: MitoSense Raises $3.5M To Treat ...

6 days from now

Built In Boston 8,892 followers ... Ratio Therapeutics plans to advance its first cancer therapy candidate into clinical trials following a new round of #funding. Ratio Therapeutics Secures …

linkedin.com

$50
OFF

Ratio Therapeutics Secures Funds For Cancer Radiotherapies

6 days from now

Jan 18, 2024 · Ratio Therapeutics has secured $50m in a Series B financing round, a significant move aimed at advancing targeted radiotherapies for cancer treatment. The funding, which …

pharmaceutical-technology.com

$50000000
OFF

Series B - Ratio Therapeutics - 2024-01-17 - Crunchbase

6 days from now

Jan 17, 2024 · Ratio Therapeutics raised $50000000 on 2024-01-17 in Series B. Search Crunchbase. ... Built In — Ratio Therapeutics Secures $50M Series B to Develop Cancer …

crunchbase.com

$50
OFF

Ratio Therapeutics Raises $50M In Series B Financing

6 days from now

Jan 17, 2024 · The Boston-based firm plans to put the funding toward advancing its fibroblast activation protein-alpha (FAP)-targeted radiopharmaceutical therapies. ... Ratio Therapeutics …

precisionmedicineonline.com

$50
OFF

Ratio Therapeutics Scores $50M Series B - VC News Daily

6 days from now

Ratio Therapeutics Inc. (Ratio), a pharmaceutical company that employs a suite of innovative technologies to develop best-in-class radiopharmaceuticals for the treatment and monitoring of …

vcnewsdaily.com